Target intelligence / Profile preview

Myostatin, Activin A, Activin B, GDF11, BMP10

Molecular classification
Growth factor, Cytokine, TGF-β superfamily
01

Overview

This entry refers to a list of closely related signaling proteins: Myostatin, Activin A, Activin B, GDF11, and BMP10. All are members of the transforming growth factor beta (TGF-β) superfamily, participating in related but distinct biological processes. As ligands, they primarily signal through similar receptor complexes, often involving ActRIIB, and are regulated by extracellular antagonists like follistatin. While each is a therapeutic target individually, the combined input is not a single canonical target.

Other names
MSTNGDF-8GDF8MyoD-factorBMP-11GDF-11
02

Mechanism of action

These proteins are ligands that bind to specific type I and type II serine/threonine kinase receptors (primarily activin type II receptors like ActRIIB, and BMP receptors), initiating intracellular SMAD signaling pathways (e.g., SMAD2/3, SMAD1/5/9). Their activity is often modulated by extracellular antagonists such as follistatin and WFIKKN proteins.

03

Biological functions

Negative regulation of skeletal muscle growthRegulation of cell proliferationCell differentiationApoptosisImmune responsesDevelopmental regulationAging regulationCardiac function modulationNeuronal function modulationStem cell activity regulationVascular biology
04

Disease associations

Muscle wasting conditions (e.g., cachexia, sarcopenia, muscular dystrophy)Metabolic diseasesInflammationCancerFibrosisReproductive disordersAging-related conditionsCardiovascular diseases (e.g., heart disease, heart malformations)Neurodegenerative conditions
05

Safety considerations

Potential for off-target tissue growthCardiac effectsMetabolic perturbationEndocrine disruptionImpact on fertilityPotential for tumorigenesisDose-dependent effectsPossible negative impact on muscleLimited clinical data (for some members)
06

Interacting drugs

Antibodies (e.g., bimagrumab)

4 more in the full profile.

07

Biomarkers

Circulating levels (Myostatin, Activin A, Activin B, GDF11, BMP10)Muscle hypertrophy (for myostatin-targeted therapies)

Beyond the preview

Go deeper on Myostatin, Activin A, Activin B, GDF11, BMP10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myostatin, Activin A, Activin B, GDF11, BMP10.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call